Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease

Study Title

A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease

Teva Identifier

TVP-1012/500 (ADAGIO)

ClinicalTrials.gov Identifier

NCT00256204

Study Status

Completed

Trial Condition(s)

Parkinson's Disease

Interventions

Drug: Rasagiline Mesylate | Other: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations
neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

30 Years to 80 Years

Trial Duration

11/01/2005 - 06/01/2009

Phase

Phase 3

Study Type

Interventional